BlogSeptember 27, 2022 Payton Nyquvest, CEO of Numinus, Sits in the Investor Hotseat on September 29th
BlogSeptember 13, 2022 What Can Psychedelics Learn From the Cannabis Industry?: Mindshifting Moments #10
BlogAugust 12, 2022 Roger McIntyre, CEO of Braxia Scientific, Sits in the Investor Hotseat on August 18th
BlogJuly 6, 2022 How Can Ancient Medicines Work with the Future of Medicine?: Mindshifting Moments – Stream #3
BlogJune 28, 2022 Damian Kettlewell, CEO of Clairvoyant Therapeutics, Sits in the Investor Hotseat – Stream #4
BlogJune 10, 2022 Dr. Chris Witowski, CEO of Psilera Bioscience, Sits in the Investor Hotseat: Stream #2
BlogMay 30, 2022 Anthony Tennyson, CEO of Awakn Life Sciences Sits in the Investor Hotseat: Stream #1
BlogNovember 16, 2021 Finding Value in the Clinical Space: A Conversation with Iter Investments Founder Dustin Robinson
InterviewsJuly 16, 2021 Jackie von Salm: On Raising $2.5 million at Psilera to Further Cutting Edge Psychedelic Research
InterviewsJune 9, 2021 Destigmatizing Psychedelics: A Conversation with Anne Philippi & Christoph Haberbauer of The New Health Club
